Skip to content

Evaluation of efficacy and safty of laparoscopic intravesical surgeries

Evaluation of efficacy and safty of laparoscopic intravesical surgeries - Evaluation of efficacy and safty of laparoscopic intravesical surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001330
Enrollment
150
Registered
2009-04-01
Start date
2010-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with lower urinary tract diseases of which intravesical surgeries are indicated for the treatments 1.Vesicoureteral reflux 2.Megaureter 3.Bladder diverticulum 4.Ureterocele 5.Hypogenesis of bladder neck etc.

Interventions

After insertion of laparoscopic trocars, intravesical surgery is performed with insufflation of CO2 gas

Sponsors

Department of Urology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with lower urinary tract diseases of which intravesical surgeries are indicated for the treatments 1.Vesicoureteral reflux In pediatric cases, breakthrough infection, progression of renal dysfunction or without spontaneous resolution, etc. In adult cases, repeated UTI, progression of renal dysfunction or females after puberty who has possibility of pregnancy, etc. 2.Megaureter Repeated UTI, progression of renal dysfunction, symptoms such as back pain, without spontaneous resolution, etc. 3.Bladder diverticulum, Ureterocele Repeated UTI, severe voiding dysfunction, etc. 4.Hypogenesis of bladder neck Severe urinary incontinence etc.

Exclusion criteria

Exclusion criteria: 1.Past history of intravesical surgery 2.Existence or past history of urothelial cancer 3.Severe complication such as heart or pulmonary disease 4.Active infection 5.Fever of 37.5 centigrade or higher 6.Pregnacy 7.Judged inappropriate with other reason by the project investigators

Design outcomes

Primary

MeasureTime frame
Adverse events

Secondary

MeasureTime frame
Postoperative improvement rate of diseases

Countries

Japan

Contacts

Public ContactAkihiro Kawauchi

Graduate School of Medical Science, Kyoto Prefectural University of Medicine Department of Urology

kawauchi@koto.kpu-m.ac.jp075-251-5595

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026